Department of Functional Anatomy and Neuroscience, Asahikawa Medical University, Asahikawa 078-8510, Japan.
Department of Neurosurgery, Asahikawa Medical University, Asahikawa 078-8510, Japan.
Int J Mol Sci. 2024 Oct 19;25(20):11261. doi: 10.3390/ijms252011261.
Demyelination and axonal degeneration are fundamental pathological characteristics of multiple sclerosis (MS), an inflammatory disease of the central nervous system (CNS). Although the molecular mechanisms driving these processes are not fully understood, hepatocyte growth factor (HGF) has emerged as a potential regulator of neuroinflammation and tissue protection in MS. Elevated HGF levels have been reported in MS patients receiving immunomodulatory therapy, indicating its relevance in disease modulation. This study investigated HGF's neuroprotective effects using transgenic mice that overexpressed HGF. The experimental autoimmune encephalomyelitis (EAE) model, which mimics MS pathology, was employed to assess demyelination and axonal damage in the CNS. HGF transgenic mice showed delayed EAE progression, with reduced CNS inflammation, decreased demyelination, and limited axonal degeneration. Scanning electron microscopy confirmed the preservation of myelin and axonal integrity in these mice. In addition, we explored HGF's effects using a cuprizone-induced demyelination model, which operates independently of the immune system. HGF transgenic mice exhibited significant protection against demyelination in this model as well. We also investigated the expression of key HGF receptors, particularly c-Met and KAI-1. While c-Met, which is associated with increased inflammation, was upregulated in EAE, its expression was significantly reduced in HGF transgenic mice, correlating with decreased neuroinflammation. Conversely, KAI-1, which has been linked to axonal protection and stability, showed enhanced expression in HGF transgenic mice, suggesting a protective mechanism against axonal degeneration. These findings underscore HGF's potential in preserving CNS structure and function, suggesting it may be a promising therapeutic target for MS, offering new hope for mitigating disease progression and enhancing neuroprotection.
脱髓鞘和轴突变性是多发性硬化症(MS)的基本病理特征,MS 是一种中枢神经系统(CNS)的炎症性疾病。虽然驱动这些过程的分子机制尚未完全理解,但肝细胞生长因子(HGF)已成为 MS 中神经炎症和组织保护的潜在调节剂。接受免疫调节治疗的 MS 患者的 HGF 水平升高,表明其与疾病调节有关。本研究使用过表达 HGF 的转基因小鼠研究了 HGF 的神经保护作用。采用实验性自身免疫性脑脊髓炎(EAE)模型模拟 MS 病理学,评估 CNS 中的脱髓鞘和轴突损伤。HGF 转基因小鼠的 EAE 进展延迟,CNS 炎症减少,脱髓鞘减少,轴突变性有限。扫描电子显微镜证实了这些小鼠中髓鞘和轴突完整性的保留。此外,我们还使用了 cuprizone 诱导的脱髓鞘模型来研究 HGF 的作用,该模型独立于免疫系统运作。HGF 转基因小鼠在该模型中也表现出对脱髓鞘的显著保护作用。我们还研究了关键的 HGF 受体的表达,特别是 c-Met 和 KAI-1。虽然与炎症增加相关的 c-Met 在 EAE 中上调,但在 HGF 转基因小鼠中其表达显著降低,与神经炎症减少相关。相反,与轴突保护和稳定性相关的 KAI-1 在 HGF 转基因小鼠中表达增强,表明存在一种针对轴突变性的保护机制。这些发现强调了 HGF 在保护 CNS 结构和功能方面的潜力,表明它可能是 MS 的一个有前途的治疗靶点,为减轻疾病进展和增强神经保护提供了新的希望。